These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 19642176)
1. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Gratwohl A; Stern M; Brand R; Apperley J; Baldomero H; de Witte T; Dini G; Rocha V; Passweg J; Sureda A; Tichelli A; Niederwieser D; Cancer; 2009 Oct; 115(20):4715-26. PubMed ID: 19642176 [TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Gratwohl A; Brand R; Apperley J; Crawley C; Ruutu T; Corradini P; Carreras E; Devergie A; Guglielmi C; Kolb HJ; Niederwieser D; Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723 [TBL] [Abstract][Full Text] [Related]
3. Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome. De Souza CA; Vigorito AC; Ruiz MA; Nucci M; Dulley FL; Funcke V; Tabak D; Azevedo AM; Byington R; Macedo MC; Saboya R; Penteado Aranha FJ; Oliveira GB; Zulli R; Martins Miranda EC; Azevedo WM; Lodi FM; Voltarelli JC; Simões BP; Colturato V; De Souza MP; Silla L; Bittencourt H; Piron-Ruiz L; Maiolino A; Gratwohl A; Pasquini R Haematologica; 2005 Feb; 90(2):232-7. PubMed ID: 15710577 [TBL] [Abstract][Full Text] [Related]
4. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children. Schneider DT; Lemburg P; Sprock I; Heying R; Göbel U; Nürnberger W Bone Marrow Transplant; 2000 May; 25(10):1079-86. PubMed ID: 10828869 [TBL] [Abstract][Full Text] [Related]
5. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G; Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401 [TBL] [Abstract][Full Text] [Related]
6. Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants. Passweg JR; Walker I; Sobocinski KA; Klein JP; Horowitz MM; Giralt SA; Br J Haematol; 2004 Jun; 125(5):613-20. PubMed ID: 15147377 [TBL] [Abstract][Full Text] [Related]
7. The hematopoietic cell transplantation-specific comorbidity index fails to predict outcomes in high-risk AML patients undergoing allogeneic transplantation--investigation of potential limitations of the index. Birninger N; Bornhäuser M; Schaich M; Ehninger G; Schetelig J Biol Blood Marrow Transplant; 2011 Dec; 17(12):1822-32. PubMed ID: 21708108 [TBL] [Abstract][Full Text] [Related]
8. Differential prognostic impact of pretransplant comorbidity on transplant outcomes by disease status and time from transplant: a single Japanese transplant centre study. Kataoka K; Nannya Y; Ueda K; Kumano K; Takahashi T; Kurokawa M Bone Marrow Transplant; 2010 Mar; 45(3):513-20. PubMed ID: 19684632 [TBL] [Abstract][Full Text] [Related]
9. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation. Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632 [TBL] [Abstract][Full Text] [Related]